SYSTEMIC SCLERODERMA
Clinical trials for SYSTEMIC SCLERODERMA explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC SCLERODERMA trials appear
Sign up with your email to follow new studies for SYSTEMIC SCLERODERMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized rehab shows promise for scleroderma patients
Symptom relief CompletedThis study tested whether a personalized, standardized rehabilitation program could improve the quality of life for people with systemic sclerosis (a disease that causes skin and joint stiffness). The trial involved 220 adults and compared the rehab program to usual care. The mai…
Matched conditions: SYSTEMIC SCLERODERMA
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 15, 2026 19:07 UTC
-
Viagra for fingers? drug tested for scleroderma ulcers
Symptom relief CompletedThis study tested whether sildenafil (the drug in Viagra) can speed up healing of painful finger ulcers in people with scleroderma. 84 participants received either sildenafil or a placebo for 90 days. The main goal was to see how long it took for the ulcers to heal.
Matched conditions: SYSTEMIC SCLERODERMA
Phase: PHASE3 • Sponsor: University Hospital, Lille • Aim: Symptom relief
Last updated Jun 12, 2026 12:09 UTC
-
Scientists probe immune Cells' role in hardening skin disease
Knowledge-focused CompletedThis study looked at whether eosinophils, a type of white blood cell, help cause fibrosis (scarring) in systemic sclerosis, an autoimmune disease that hardens skin and lungs. Researchers compared blood and tissue samples from 40 patients with systemic sclerosis and 30 healthy vol…
Matched conditions: SYSTEMIC SCLERODERMA
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:08 UTC
-
Tiny particles may hold key to lupus and scleroderma mysteries
Knowledge-focused CompletedThis study looked at tiny particles in the blood and urine of 208 people with lupus or scleroderma. Researchers measured changes in these particles over 12 months to see if they could help predict disease activity or lead to new treatments. The goal was to better understand these…
Matched conditions: SYSTEMIC SCLERODERMA
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:26 UTC